A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator controlled Study To Evaluate The Efficacy And Safety Of Faricimab In Patients With Macular Edema Secondary To Central Retinal Or Hemiretinal Vein Occlusion.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 730 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Triple (Participant, Investigator, Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion |
| Actual Study Start Date : | March 2, 2021 |
| Estimated Primary Completion Date : | August 11, 2022 |
| Estimated Study Completion Date : | July 13, 2023 |
